The DOI matches its Crossref record.
Mild cognitive impairment – Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment.
Open accessAbstract
Abstract.: The First Key Symposium was held in Stockholm, Sweden, 2–5 September 2003. The aim of the symposium was to integrate clinical and epidemiological perspectives on the topic of Mild Cognitive Impairment (MCI). A multidisciplinary, international group of experts discussed the current status and future directions of MCI, with regard to clinical presentation, cognitive and functional assessment, and the role of neuroimaging, biomarkers and genetics. Agreement on new perspectives, as well as recommendations for management and future research were discussed by the international working group. The specific recommendations for the general MCI criteria include the following: (i) the person is neither normal nor demented; (ii) there is evidence of cognitive deterioration shown by either objectively measured decline over time and/or subjective report of decline by self and/or informant in conjunction with objective cognitive deficits; and (iii) activities of daily living are preserved and complex instrumental functions are either intact or minimally impaired.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It seems quite obvious that both the dementia severity in AD patients and the pattern of cognitive deficits in MCI patients (only amnestic, amnestic plus other domains, or not amnestic at all [41]) have a great impact on the expected pattern of hippocampal regional atrophy.”
From Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease (2015) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sorted by citations
Items 101–200 of 209
Cheng, Y.-W., Chen, T.-F., & Chiu, M.-J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s123428 · Cited by 150
Walker, K. A., Chen, J., Shi, L., Yang, Y., Fornage, M., Zhou, L., Schlosser, P., Surapaneni, A., Grams, M. E., Duggan, M. R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf5681 · Cited by 148
Evidence of Neuronal Compensation During Episodic Memory in Subjective Memory Impairment
Erk, S. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.80 · Cited by 147
Herukka, S.-K., Simonsen, A. H., Andreasen, N., Baldeiras, I., Bjerke, M., Blennow, K., Engelborghs, S., Frisoni, G. B., Gabryelewicz, T., Galluzzi, S., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.09.009 · Cited by 141
Self-citationMarkers of neuroinflammation associated with Alzheimer’s disease pathology in older adults
Popp, J., Oikonomidi, A., Tautvydaitė, D., Dayon, L., Bacher, M., Migliavacca, E., Henry, H., Kirkland, R., Severin, I., Wojcik, J., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.01.020 · Cited by 136
Staekenborg, S. S., Koedam, E. L. G. E., Henneman, W. J. P., Stokman, P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.108.531343 · Cited by 139
Sub-regional hippocampal injury is associated with fornix degeneration in Alzheimer’s disease.
Lee, D. Y., Fletcher, E., Carmichael, O. T., Singh, B., Mungas, D., Reed, B., Martinez, O., Buonocore, M. H., Persianinova, M., & DeCarli, C. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00001 · Cited by 137
Self-citationUse of the Virtual Action Planning Supermarket for the Diagnosis of Mild Cognitive Impairment
Werner, P., Rabinowitz, S., Klinger, E., Korczyn, A. D., & Josman, N. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000204915 · Cited by 135
Clerx, L., Visser, P. J., Verhey, F., & Aalten, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110797 · Cited by 132
Self-citationCornelis, E., Gorus, E., Beyer, I., Bautmans, I., & De Vriendt, P. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002250 · Cited by 133
NADPH-oxidase activation and cognition in Alzheimer disease progression
Ansari, M. A., & Scheff, S. W. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.025 · Cited by 131
“One of the presumed early transition stages is the clinical diagnosis of mild cognitive impairment (MCI), defined as an individual expressing consistent, measurable memory impairment without dementia or significant disability related to activities of daily living [3, 4].”
BackgroundPatterns of cognitive decline prior to dementia in persons with mild cognitive impairment
Cloutier, S., Chertkow, H., Kergoat, M.-J., Gauthier, S., & Belleville, S. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142910 · Cited by 124
Practice effects predict cognitive outcome in amnestic mild cognitive impairment
Duff, K., Lyketsos, C. G., Beglinger, L. J., Chelune, G., Moser, D. J., Arndt, S., Schultz, S. K., Paulsen, J. S., Petersen, R. C., & McCaffrey, R. J. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318209dd3a · Cited by 126
Self-citationMicrostructural white matter changes in cognitively normal individuals at risk of amnestic MCI
Zhuang, L., Sachdev, P. S., Trollor, J. N., Kochan, N. A., Reppermund, S., Brodaty, H., & Wen, W. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661f4d · Cited by 125
Regional pattern of white matter microstructural changes in normal aging, MCI, and AD
Lee, D. Y., Fletcher, E., Martinez, O., Ortega, M., Zozulya, N., Kim, J., Tran, J., Buonocore, M., Carmichael, O., & DeCarli, C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c33afb · Cited by 122
Self-citationCirculating Biomarkers of Cognitive Decline and Dementia
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120
Gallagher, D., Kiss, A., Lanctot, K., & Herrmann, N. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.05.002 · Cited by 122
Ginsberg, S. D., Che, S., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03641.x · Cited by 111
Wolfsgruber, S., Polcher, A., Koppara, A., Kleineidam, L., Frölich, L., Peters, O., Hüll, M., Rüther, E., Wiltfang, J., Maier, W., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161252 · Cited by 114
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
Meyer, P.-F., Tremblay-Mercier, J., Leoutsakos, J., Madjar, C., Lafaille-Maignan, M.-É., Savard, M., Rosa-Neto, P., Poirier, J., Etienne, P., Breitner, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007232 · Cited by 113
Barca, M. L., Engedal, K., & Selbæk, G. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000313533 · Cited by 114
Aβ-amyloid and Tau Imaging in Dementia
Villemagne, V. L., Doré, V., Bourgeat, P., Burnham, S. C., Laws, S., Salvado, O., Masters, C. L., & Rowe, C. C. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.006 · Cited by 110
Copenhaver, B. R., Rabin, L. A., Saykin, A. J., Roth, R. M., Wishart, H. A., Flashman, L. A., Santulli, R. B., McHugh, T. L., & Mamourian, A. C. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.01.015 · Cited by 112
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Bos, I., Vos, S., Vandenberghe, R., Scheltens, P., Engelborghs, S., Frisoni, G., Molinuevo, J. L., Wallin, A., Lleó, A., Popp, J., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0396-5 · Cited by 112
Self-citationBertola, L., Mota, N. B., Copelli, M., Rivero, T., Diniz, B. S., Romano-Silva, M. A., Ribeiro, S., & Malloy-Diniz, L. F. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00185 · Cited by 107
Leibson, C. L., Long, K. H., Ransom, J. E., Roberts, R. O., Hass, S. L., Duhig, A. M., Smith, C. Y., Emerson, J. A., Pankratz, V. S., & Petersen, R. C. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.01.007 · Cited by 110
Self-citationLim, Y. Y., Villemagne, V. L., Laws, S. M., Ames, D., Pietrzak, R. H., Ellis, K. A., Harrington, K., Bourgeat, P., Bush, A. I., Martins, R. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086498 · Cited by 110
Discriminative and predictive power of an informant report in mild cognitive impairment
Isella, V (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.069765 · Cited by 109
Pluta, J., Yushkevich, P., Das, S., & Wolk, D. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111931 · Cited by 107
Casas-Herrero, A., Cadore, E. L., Zambom-Ferraresi, F., Idoate, F., Millor, N., Martínez-Ramirez, A., Gómez, M., Rodriguez-Mañas, L., Marcellán, T., de Gordoa, A. R., et al. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1438 · Cited by 105
Alzheimer disease pathology and the cerebrospinal fluid proteome
Dayon, L., Núñez Galindo, A., Wojcik, J., Cominetti, O., Corthésy, J., Oikonomidi, A., Henry, H., Kussmann, M., Migliavacca, E., Severin, I., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0397-4 · Cited by 101
Patterns of Mild Cognitive Impairment After Treatment of Depression in the Elderly
Bhalla, R. K., Butters, M. A., Becker, J. T., Houck, P. R., Snitz, B. E., Lopez, O. L., Aizenstein, H. J., Raina, K. D., DeKosky, S. T., & Reynolds, C. F. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318190b8d8 · Cited by 105
Carotid Intima-Media Thickness and Cognitive Function in Elderly Women: A Population-Based Study
Komulainen, P., Kivipelto, M., Lakka, T. A., Hassinen, M., Helkala, E.-L., Patja, K., Nissinen, A., & Rauramaa, R. (2007) · Neuroepidemiology · doi:10.1159/000108112 · Cited by 98
Self-citationCortical thinning related to periventricular and deep white matter hyperintensities
Seo, S. W., Lee, J.-M., Im, K., Park, J.-S., Kim, S.-H., Kim, S. T., Ahn, H.-J., Chin, J., Cheong, H.-K., Weiner, M. W., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.003 · Cited by 95
Dhiman, K., Gupta, V. B., Villemagne, V. L., Eratne, D., Graham, P. L., Fowler, C., Bourgeat, P., Li, Q., Collins, S., Bush, A. I., et al. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12005 · Cited by 93
Self-citationSeshadri, S., Beiser, A., Au, R., Wolf, P. A., Evans, D. A., Wilson, R. S., Petersen, R. C., Knopman, D. S., Rocca, W. A., Kawas, C. H., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.002 · Cited by 97
Self-citationClark, C., Lewczuk, P., Kornhuber, J., Richiardi, J., Maréchal, B., Karikari, T. K., Blennow, K., Zetterberg, H., & Popp, J. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00805-8 · Cited by 88
Self-citationDiamond, K., Mowszowski, L., Cockayne, N., Norrie, L., Paradise, M., Hermens, D. F., Lewis, S. J. G., Hickie, I. B., & Naismith, S. L. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-142061 · Cited by 95
Ott, B. R., Jones, R. N., Daiello, L. A., de la Monte, S. M., Stopa, E. G., Johanson, C. E., Denby, C., & Grammas, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00245 · Cited by 91
The determinants and longitudinal course of post-stroke mild cognitive impairment
SACHDEV, P. S., CHEN, X., BRODATY, H., THOMPSON, C., ALTENDORF, A., & WEN, W. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990579 · Cited by 90
Vecchio, F., Miraglia, F., Iberite, F., Lacidogna, G., Guglielmi, V., Marra, C., Pasqualetti, P., Tiziano, F. D., & Rossini, P. M. (2018) · Annals of Neurology · doi:10.1002/ana.25289 · Cited by 89
Predictive Value of Mild Cognitive Impairment for Dementia
Baars, M. A. E., van Boxtel, M. P. J., Dijkstra, J. B., Visser, P. J., van den Akker, M., Verhey, F. R. J., & Jolles, J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000200465 · Cited by 87
Self-citationBai, F., Watson, D. R., Shi, Y., Wang, Y., Yue, C., YuhuanTeng, Wu, D., Yuan, Y., & Zhang, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024271 · Cited by 85
Haley, A. P., Hoth, K. F., Gunstad, J., Paul, R. H., Jefferson, A. L., Tate, D. F., Ono, M., Jerskey, B. A., Poppas, A., Sweet, L. H., et al. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b208ef · Cited by 85
Early secure attachment as a protective factor against later cognitive decline and dementia
Walsh, E., Blake, Y., Donati, A., Stoop, R., & von Gunten, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00161 · Cited by 84
Kurz, A. F., Leucht, S., & Lautenschlager, N. T. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211001001 · Cited by 82
Boots, L. M., de Vugt, M. E., Withagen, H. E., Kempen, G. I., & Verhey, F. R. (2016) · JMIR Research Protocols · doi:10.2196/resprot.5142 · Cited by 79
Neuroimaging in Parkinson’s disease dementia: connecting the dots
Weil, R. S., Hsu, J. K., Darby, R. R., Soussand, L., & Fox, M. D. (2019) · Brain Communications · doi:10.1093/braincomms/fcz006 · Cited by 71
Determinants of the desire to institutionalize in Alzheimer’s caregivers
Gallagher, D., Ni Mhaolain, A., Crosby, L., Ryan, D., Lacey, L., Coen, R. F., Walsh, C., Coakley, D., Walsh, J. B., Cunningham, C., et al. (2011) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317511400307 · Cited by 71
Preclinical AD Workgroup staging: Pathological correlates and potential challenges
Jicha, G. A., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Riley, K. P., Cooper, G. E., Stiles, N., Mendiondo, M. S., Smith, C. D., Van Eldik, L. J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.018 · Cited by 71
Rawtaer, I., Gao, Q., Nyunt, M. S. Z., Feng, L., Chong, M. S., Lim, W. S., Lee, T.-S., Yap, P., Yap, K. B., & Ng, T. P. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160862 · Cited by 68
Bloch, L., Friedrich, C. M., & Initiative, F. T. A. D. N. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00879-4 · Cited by 68
d’Angremont, E., Begemann, M. J. H., van Laar, T., & Sommer, I. E. C. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.1835 · Cited by 71
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
for the Dominantly Inherited Alzheimer Network (DIAN), Twohig, D., Rodriguez-Vieitez, E., Sando, S. B., Berge, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., Patra, K., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0624-z · Cited by 68
“Clinical diagnoses of MCI or AD were based on the International Working Group on Mild Cognitive Impairment Criteria [63] and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association criteria [34, 35].”
MethodSelf-citationKoppel, J., Sunday, S., Goldberg, T. E., Davies, P., Christen, E., & Greenwald, B. S. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.028 · Cited by 65
Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., & Feng, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010386.pub2 · Cited by 66
The Framingham Brain Donation Program: Neuropathology Along the Cognitive Continuum
Au, R., Seshadri, S., Knox, K., Beiser, A., J. Himali, J., J. Cabral, H., Auerbach, S., C. Green, R., A. Wolf, P., & C. McKee, A. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322609 · Cited by 65
“Persons meeting criteria for MCI are also categorized as having either amnestic MCI with isolated memory or memory deficits along with other cognitive deficits, and non-amnestic MCI, with either a single or multiple non-memory deficits [16-18].”
BackgroundThe prevalence of obstructive sleep apnea in mild cognitive impairment: a systematic review
Mubashir, T., Abrahamyan, L., Niazi, A., Piyasena, D., Arif, A. A., Wong, J., Osorio, R. S., Ryan, C. M., & Chung, F. (2019) · BMC Neurology · doi:10.1186/s12883-019-1422-3 · Cited by 65
Yang, H., Leaver, A. M., Siddarth, P., Paholpak, P., Ercoli, L., St. Cyr, N. M., Eyre, H. A., Narr, K. L., Khalsa, D. S., & Lavretsky, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00277 · Cited by 61
Smailagic, N., Lafortune, L., Kelly, S., Hyde, C., & Brayne, C. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171125 · Cited by 61
A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives
On behalf of the European Association of Nuclear Medicine, Morbelli, S., Garibotto, V., Van De Giessen, E., Arbizu, J., Chételat, G., Drezgza, A., Hesse, S., Lammertsma, A. A., Law, I., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3098-2 · Cited by 61
Forti, P., Maioli, F., Pisacane, N., Rietti, E., Montesi, F., & Ravaglia, G. (2007) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.01.023 · Cited by 60
Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort
Ravaglia, G., Forti, P., Lucicesare, A., Pisacane, N., Rietti, E., Mangialasche, F., Cecchetti, R., Patterson, C., & Mecocci, P. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1306 · Cited by 59
Sabbagh, M. N., Shah, F., Reid, R. T., Sue, L., Connor, D. J., Peterson, L. K. N., & Beach, T. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1771 · Cited by 57
Wang, X., Liu, G., Gao, Q., Li, N., & Wang, R. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13196 · Cited by 51
The relationship between episodic long-term memory and white matter integrity in normal aging
Charlton, R. A., Barrick, T. R., Markus, H. S., & Morris, R. G. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.08.018 · Cited by 55
Haldenwanger, A., Eling, P., Kastrup, A., & Hildebrandt, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101203 · Cited by 54
Subtyping of mild cognitive impairment using a deep learning model based on brain atrophy patterns
Kwak, K., Giovanello, K. S., Bozoki, A., Styner, M., & Dayan, E. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100467 · Cited by 47
Mangialasche, F., Baglioni, M., Cecchetti, R., Kivipelto, M., Ruggiero, C., Piobbico, D., Kussmaul, L., Monastero, R., Brancorsini, S., & Mecocci, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142052 · Cited by 53
Self-citationWiels, W. A., Wittens, M. M. J., Zeeuws, D., Baeken, C., & Engelborghs, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.707580 · Cited by 52
Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P. P., Frisoni, G. B., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000348354 · Cited by 53
Self-citationRole of cognitive reserve in progression from mild cognitive impairment to dementia
Allegri, R. F., Taragano, F. E., Krupitzki, H., Serrano, C. M., Dillon, C., Sarasola, D., Feldman, M., Tufró, G., Martelli, M., & Sanchez, V. (2010) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642010dn40100005 · Cited by 53
Reda, F., Gorgoni, M., Lauri, G., Truglia, I., Cordone, S., Scarpelli, S., Mangiaruga, A., D'Atri, A., Ferrara, M., Lacidogna, G., et al. (2017) · Brain Sciences · doi:10.3390/brainsci7050051 · Cited by 52
Bangen, K. J., Initiative, F. T. A. D. N., Clark, A. L., Werhane, M., Edmonds, E. C., Nation, D. A., Evangelista, N., Libon, D. J., Bondi, M. W., & Delano-Wood, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150900 · Cited by 51
Collingwood, C., Paddick, S.-M., Kisoli, A., Dotchin, C. L., Gray, W. K., Mbowe, G., Mkenda, S., Urasa, S., Mushi, D., Chaote, P., et al. (2014) · Global Health Action · doi:10.3402/gha.v7.25988 · Cited by 47
Leisure-time physical activity and the risk of incident dementia: the mayo clinic study of aging
Krell-Roesch, J., Feder, N. T., Roberts, R. O., Mielke, M. M., Christianson, T. J., Knopman, D. S., Petersen, R. C., & Geda, Y. E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171141 · Cited by 50
Homann, J., Osburg, T., Ohlei, O., Dobricic, V., Deecke, L., Bos, I., Vandenberghe, R., Gabel, S., Scheltens, P., Teunissen, C. E., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.840651 · Cited by 46
Self-citationChan, J. Y. C., Bat, B. K. K., Wong, A., Chan, T. K., Huo, Z., Yip, B. H. K., Kowk, T. C. Y., & Tsoi, K. K. F. (2022) · Neuropsychology Review · doi:10.1007/s11065-021-09523-2 · Cited by 43
Tonga, J. B., Šaltytė Benth, J., Arnevik, E. A., Werheid, K., Korsnes, M. S., & Ulstein, I. D. (2021) · International Psychogeriatrics · doi:10.1017/s1041610220000216 · Cited by 42
Lim, B., Sando, S. B., Grøntvedt, G. R., Bråthen, G., & Diamandis, E. P. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.013 · Cited by 39
Jones, S. A., De Marco, M., Manca, R., Bell, S. M., Blackburn, D. J., Wilkinson, I. D., Soininen, H., & Venneri, A. (2019) · Cortex · doi:10.1016/j.cortex.2019.04.008 · Cited by 37
Arsenault, L. N., Matthan, N., Scott, T. M., Dallal, G., Lichtenstein, A. H., Folstein, M. F., Rosenberg, I., & Tucker, K. L. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp089 · Cited by 36
Aarsland, D., Khalifa, K., Bergland, A. K., Soennesyn, H., Oppedal, K., Holteng, L. B. A., Oesterhus, R., Nakling, A., Jarholm, J. A., de Lucia, C., et al. (2023) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.10.002 · Cited by 36
Operationalizing mild cognitive impairment criteria in small vessel disease: the VMCI‐Tuscany Study
Salvadori, E., Poggesi, A., Valenti, R., Pracucci, G., Pescini, F., Pasi, M., Nannucci, S., Marini, S., Del Bene, A., Ciolli, L., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.010 · Cited by 36
Stein, J., Luppa, M., Luck, T., Maier, W., Wagner, M., Daerr, M., van den Bussche, H., Zimmermann, T., Köhler, M., Bickel, H., et al. (2012) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318209dd08 · Cited by 35
Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9190-2 · Cited by 34
Using narratives in differential diagnosis of neurodegenerative syndromes
Faroqi-Shah, Y., Treanor, A., Ratner, N. B., Ficek, B., Webster, K., & Tsapkini, K. (2020) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2020.105994 · Cited by 32
Dang, C., Harrington, K. D., Lim, Y. Y., Ames, D., Hassenstab, J., Laws, S. M., Yassi, N., Hickey, M., Rainey-Smith, S., Robertson, J., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180507 · Cited by 31
Gallagher, D., Kiss, A., Lanctot, K. L., & Herrmann, N. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18m12331 · Cited by 34
Stonsaovapak, C., Hemrungroj, S., Terachinda, P., & Piravej, K. (2020) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2020.03.023 · Cited by 33
Nasrouei, S., Rattel, J. A., Liedlgruber, M., Marksteiner, J., & Wilhelm, F. H. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.11.003 · Cited by 30
Bier, N., Grenier, S., Brodeur, C., Gauthier, S., Gilbert, B., Hudon, C., Lepage, É., Ouellet, M.-C., Viscogliosi, C., & Belleville, S. (2015) · International Psychogeriatrics · doi:10.1017/s1041610214001902 · Cited by 28
Biomarker-based signature of alzheimer's disease in pre-MCI individuals
Chipi, E., Salvadori, N., Farotti, L., & Parnetti, L. (2019) · Brain Sciences · doi:10.3390/brainsci9090213 · Cited by 27
Lifetime coffee consumption, pineal gland volume, and sleep quality in late life
Park, J., Han, J. W., Lee, J. R., Byun, S., Suh, S. W., Kim, T., Yoon, I. Y., & Kim, K. W. (2018) · SLEEP · doi:10.1093/sleep/zsy127 · Cited by 27
Sertraline Improves Executive Function in Patients With Vascular Cognitive Impairment
Royall, D. R., Cordes, J. A., Román, G., Velez, A., Edwards, A., Schillerstrom, J. S., & Polk, M. J. (2009) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2009.21.4.445 · Cited by 26
Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
Vacher, M., Porter, T., Villemagne, V. L., Milicic, L., Peretti, M., Fowler, C., Martins, R., Rainey-Smith, S., Ames, D., Masters, C. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53604-5 · Cited by 26
Can the DSM-5 framework enhance the diagnosis of MCI?
Ganguli, M. (2013) · Neurology · doi:10.1212/01.wnl.0000436944.01023.e5 · Cited by 26
Automated activity-aware prompting for activity initiation
Holder, L. B., & Cook, D. J. (2013) · Gerontechnology · doi:10.4017/gt.2013.11.4.005.00 · Cited by 24
Pelka, O., Friedrich, C. M., Nensa, F., Mönninghoff, C., Bloch, L., Jöckel, K.-H., Schramm, S., Sanchez Hoffmann, S., Winkler, A., Weimar, C., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236868 · Cited by 22
“[52] MCI criteria were used to diagnose aMCI.”
MethodDéjos, M., Sauzéon, H., & N’Kaoua, B. (2012) · Revue Neurologique · doi:10.1016/j.neurol.2011.09.005 · Cited by 20
Metadata
- Authors
- Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., Arai, H., Basun, H., Blennow, K., De Leon, M., DeCarli, C., Erkinjuntti, T., Giacobini, E., Graff, C., Hardy, J., Jack, C., Jorm, A., Ritchie, K., Van Duijn, C., Visser, P., & Petersen, R. C.
- Affiliations
- Karolinska Institutet (SE)
- Johns Hopkins University (US)
- Tohoku University (JP)
- Uppsala University (SE)
- University of Gothenburg (SE)
- University of California, Davis (US)
- University of Helsinki (FI)
- University of Geneva (CH)
- National Institutes of Health (US)
- Mayo Clinic (US)
- Australian National University (AU)
- Inserm (FR)
- Maastricht University (NL)
- Corresponding author
- Winblad, B.
- ORCID
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2004-08-20
- Volume
- 256
- Issue
- 3
- Pages
- 240-246
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2055649795
- Cited by
- 4,946
- References
- 0
- Citations by year
- 2026: 157 · 2025: 234 · 2024: 272 · 2023: 228 · 2022: 267 · 2021: 271 · 2020: 306 · 2019: 292 · 2018: 248 · 2017: 263 · 2016: 267 · 2015: 284 · 2014: 256 · 2013: 263 · 2012: 254
- FWCI
- 54.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- mild cognitive impairment, diagnostic criteria, cognitive decline, activities of daily living, functional assessment, neuroimaging, biomarkers, dementia prevention, clinical management guidelines
- MeSH terms
- Aged, Cognition Disorders, Diagnostic Imaging, Humans, Neuropsychological Tests, Biomarkers, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
